CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease

Relation Between Kidney Function, Proteinuria, and Adverse Outcomes

(2010) Brenda R. Hemmelgarn   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Monocytes in atherosclerosis: subsets and functions

(2010) Kevin J. Woollard et al.   Nature Reviews Cardiology

Genetic diversity of CX3CR1 gene and coronary artery disease: New insights through a meta-analysis

(2009) Stavros Apostolakis et al.   ATHEROSCLEROSIS

CCR5Δ32 genotype is associated with outcome in type 2 diabetes mellitus

(2009) Friso L.H. Muntinghe et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Monocyte heterogeneity in obesity and subclinical atherosclerosis

(2009) K. S. Rogacev et al.   EUROPEAN HEART JOURNAL

Maraviroc: a new CCR5 antagonist

(2009) Shilpa Sayana et al.   Expert Review of Anti-Infective Therapy

CCR5 Deletion Protects Against Inflammation-Associated Mortality in Dialysis Patients

(2009) F. L.H. Muntinghe et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice

(2009) Rory R Koenen et al.   NATURE MEDICINE

Haemodialysis-induced transient CD16+ monocytopenia and cardiovascular outcome

(2009) K. S. Rogacev et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Cardiorenal Syndrome

(2008) Claudio Ronco et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY